12:00 AM
May 12, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Peripheral benzodiazepine receptor (TSPO; PBR); Mdm2 p53 binding protein homolog (MDM2; HDM2)


INDICATION: Brain cancer

In vitro studies identified an inhibitor of MDM2/p53 binding and TSPO that could help treat glioblastoma. Chemical synthesis and in vitro testing of 2-phenylindolylglyoxylyl dipeptides identified a compound that bound...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >